SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-028718
Filing Date
2024-02-28
Accepted
2024-02-28 16:10:14
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 tm246927-3_424b5.htm 424B5 393717
2 GRAPHIC lg_celldextherapeutics-4c.jpg GRAPHIC 16631
  Complete submission text file 0001104659-24-028718.txt   418032
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275300 | Film No.: 24695422
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)